According to the present results, TET2 was a master DNA demethylase that regulated angiogenesis and post‐ischemic, thus providing evidence for the potential therapeutic role of targeting TET2 in the treatment of ischemic diseases. The gene discussed is TET2; the disease is ischemic disease.